Claims
- 1. A compound, 2,4-diamino-5-(4-amino-3,5-dimethoxybenzyl)-pyrimidine or a pharmaceutically acceptable acid addition salt thereof.
- 2. A compound in accordance with claim 1, 2,4-diamino-5-(4-amino-3,5-dimethoxybenzyl)-pyrimidine monohydrochloride.
- 3. A compound in accordance with claim 1, 2,4-diamino-5-(4-amino-3,5-dimethoxybenzyl)-pyrimidine dihydrochloride.
- 4. A compound, 2,4-diamino-5-[4-(dimethylamino)-3,5-dimethoxy-benzyl]-pyrimidine, or a pharmaceutically acceptable acid addition salt thereof.
Priority Claims (2)
Number |
Date |
Country |
Kind |
13057/73 |
Sep 1973 |
CHX |
|
10063/74 |
Jul 1974 |
CHX |
|
Parent Case Info
This is a division, of application Ser. No. 63,292 filed Aug. 2, 1979, now abandoned which in turn is a continuation of U.S. patent application Ser. No. 795,828, filed May 11, 1977, now abandoned, which in turn is a continuation of Ser. No. 504,416, filed Sept. 9, 1974, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
2670351 |
Jacob |
Feb 1954 |
|
3692787 |
Roth et al. |
Sep 1982 |
|
Non-Patent Literature Citations (2)
Entry |
Roth J. Med. Pharm. Chem. 5, (1962), pp. 1103-1125. |
Falco et al., JACS vol. 23, pp. 3258-3262, (1951). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
63292 |
Aug 1979 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
795828 |
May 1977 |
|
Parent |
504416 |
Sep 1974 |
|